The most common side effects are gastrointestinal , including nausea, vomiting, diarrhoea, constipation, and abdominal discomfort
or collapse (possible anaphylaxis) Severe abdominal pain (possible pancreatitis) Signs of infection at the injection site (redness, swelling, discharge, or fever) Persistent vomiting or inability to tolerate fluids Chest pain, palpitations, or difficulty breathing Severe dizziness or loss of consciousness For non-urgent concerns, contact your GP or call NHS 111 for advice
Week 1: Abdomen, right side Week 2: Left thigh, outer portion Week 3: Abdomen, left side Week 4: Right thigh, outer portion Week 5: Abdomen, right side (several inches from the Week 1 spot) Week 6: Left thigh, different spot from Week 2 If you have a partner who can help, add the upper arm into the rotation for even more variety
Explore our products: The Receptor Profiles: Where Retatrutide and Tirzepatide Diverge Tirzepatide is a dual agonist at the GLP-1 receptor (GLP-1R) and the glucose-dependent insulinotropic polypeptide receptor (GIPR)